Lv4
740 积分 2024-07-22 加入
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
15天前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
16天前
已完结
Should CAR-T cells be used as monotherapy?
16天前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
23天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
CAR-T entering a new “phase”: Improving CAR-T function by harnessing phase separation
2个月前
已完结
Transforming TGF-β suppression into IL-15 stimulation: Advancing engineered CAR-T therapy for solid tumors
3个月前
已完结
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
3个月前
已完结
Deciphering the response to BCMA CAR T cell therapy
6个月前
已完结
Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up
7个月前
已完结
皖公网安备34019202002308
